Shionogi & Co Ltd ADR (SGIOY PINK) stock market data APIs
$8.5929
0.3(3.5%)
as of June 9, 2026
Try our APIs with
free plan!
Shionogi & Co Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Prev. Close
8.5929
Open
8.8942
High
8.8952
Low
8.4994
52 wk Range
7.7489-11.4761
Market Cap
14 756 M
P/E Ratio
11.56
Shares Outstanding
1 702 M
Revenue
499 677 M
Dividends (Yield)
0.0246
Beta
0.031
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shionogi & Co Ltd ADR data using free add-ons & libraries
Get Shionogi & Co Ltd ADR Fundamental Data
Shionogi & Co Ltd ADR Fundamental data includes:
- Net Revenue: 499 677 M
- EBITDA: 151 324 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-11
- EPS/Forecast: 0.1904
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shionogi & Co Ltd ADR News
New
New Polymorph of Indomethacin Discovered
Cover of the June 2026 issue of Crystal Growth & Design, featuring this research. - Joint Research Involving Rigaku Published in Crystal Growth & Design - TOKYO, June 09, 2026--(BUSINESS WIRE)--Riga...
Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
XOCOVA® logoXOCOVA® carton packagingXOCOVA® blister packXOCOVA® carton and blister pack combinedShionogi Inc. building exterior Approval is based on SCORPIO-PEP, the only Phase 3 study of an oral...
PrEP Wisdom: ViiV Healthcare Launches New Campaign to Support Informed HIV Prevention Choices
TV personality Michelle Visage lends her voice to raise awareness about important differences in long-acting injectable PrEP options More information and resources for people who could benefit from Pr...
New England Journal of Medicine Publishes Shionogi Study Demonstrating Ensitrelvir Prevents COVID-19 Following Exposure
SCORPIO-PEP is the first and only Phase 3 study of an oral antiviral to meet the primary endpoint of preventing symptomatic COVID-19 following exposure to an infected individual* Ensitrelvir is an in...
Get Shionogi & Co Ltd ADR fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
